AstraZeneca
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
US to move COVID-19 vaccines, treatments to private markets in 2023
AION, aMoon up for top scientific innovation award
COVID-19 booster shots are crucial, according to a Yale study
AstraZeneca new vaccine could protect against Beta variant
Also known as the South African variant, the WHO considers it to be one of concern • human trials of the vaccine have begun
Mixing COVID vaccines results in higher chance of side effects - study
None of the participants were hospitalized for their side effects, most of which were experienced within 48 hours of receiving the vaccine.
US to share up to 60 mln AstraZeneca vaccine doses globally -White House
White House Press Secretary Jen Psaki said the United States would release the doses to other countries as they become available.
Coronavirus: Israel looks to re-route AstraZeneca vaccines
A day after Netanyahu told Israelis to get ready to be jabbed again in six months, Prof. Nachman Ash reaffirms that there are no certainties on when the next shot will be needed.
COVAX supplies 72,000 AstraZeneca vaccine doses to Palestinian Authority
The shipment that went into the West Bank and Gaza on Monday, is the second such shipment and brings the total of vaccines the PA has received to 383,440.
AstraZeneca could have COVID vaccine against variant by end-2021 - report
British and European Union medicine regulators have said that the overall benefits of using the vaccine outweigh any risks of rare clotting.
Italy reported four clot deaths after AstraZeneca shots, data shows
AIFA said there had been 11 cases in Italy of people developing one of two types of blood clots following their AstraZeneca shot - CVST and thrombosis involving multiple blood vessels.
EU drug regulator finds link between AstraZeneca vaccine and blood clots
Experts say that, even if a causal link between the vaccine and blood clots is proved, the risks to the general population of getting a serious clot are small compared to the risks of COVID-19.
Coronavirus: US puts J&J in charge, removes AstraZeneca from faulty plant
The government’s move to have the facility make only the J&J single-dose vaccine is meant to avoid future mix-ups.
US stops AstraZeneca vaccine production at Baltimore plant -NY Times
The administration has put Johnson & Johnson in charge of the troubled manufacturing plant, the report said.
